Green synthesis of gold nanoparticles: An eco-friendly approach

PB Santhosh, J Genova, H Chamati - Chemistry, 2022 - mdpi.com
By virtue of their unique physicochemical properties, gold nanoparticles (AuNPs) have
gained significant interest in a broad range of biomedical applications such as sensors …

Advances in quantum dot-based biosensors for DNA-modifying enzymes assay

Q Zhang, X Zhang, F Ma, C Zhang - Coordination Chemistry Reviews, 2022 - Elsevier
DNA-modifying enzymes participate in various genetic functions (eg, DNA replication,
repairing, and recombination) through alternating certain DNA sequence, and the …

The global burden of leukemia and its attributable factors in 204 countries and territories: findings from the global burden of disease 2019 study and projections to …

M Du, W Chen, K Liu, L Wang, Y Hu, Y Mao… - Journal of …, 2022 - Wiley Online Library
Background. Leukemia is a common malignancy that has four main subtypes and is a threat
to human health. Understanding the epidemiological status of leukemia and its four main …

Fisetin, a potent anticancer flavonol exhibiting cytotoxic activity against neoplastic malignant cells and cancerous conditions: A scoping, comprehensive review

R Kubina, K Krzykawski, A Kabała-Dzik, RD Wojtyczka… - Nutrients, 2022 - mdpi.com
Diet plays a crucial role in homeostasis maintenance. Plants and spices containing
flavonoids have been widely used in traditional medicine for thousands of years. Flavonols …

Disease burden, risk factors, and trends of leukaemia: a global analysis

J Huang, SC Chan, CH Ngai, V Lok, L Zhang… - Frontiers in …, 2022 - frontiersin.org
Leukaemia accounted for approximately 2.5% of all new cancer incidence and 3.1% of
cancer-related mortality. The investigation of its risk factors and epidemiologic trends could …

Trends in disease burden of chronic lymphocytic leukemia at the global, regional, and national levels from 1990 to 2019, and projections until 2030: a population …

Y Ou, Y Long, L Ji, Y Zhan, T Qiao, X Wang… - Frontiers in …, 2022 - frontiersin.org
Background The prognosis of chronic lymphocytic leukemia (CLL) has been improved
dramatically, but there are limited studies focusing on CLL disease burden on a global …

Reactive oxygen species and metabolism in leukemia: a dangerous liaison

M Romo-González, C Ijurko… - Frontiers in …, 2022 - frontiersin.org
Reactive oxygen species (ROS), previously considered toxic by-products of aerobic
metabolism, are increasingly recognized as regulators of cellular signaling. Keeping ROS …

The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden …

Y Yao, X Lin, F Li, J Jin, H Wang - Biomedical engineering online, 2022 - Springer
Background Chronic lymphocytic leukemia (CLL) is the most prevalent subtype of leukemia
in Western countries, causing a substantial health burden on patients and society …

Regional and national burden of leukemia and its attributable burden to risk factors in 21 countries and territories of North Africa and Middle East, 1990–2019: results …

M Heidari-Foroozan, S Saeedi Moghaddam… - Journal of Cancer …, 2023 - Springer
Purpose Regional and national data on leukemia's burden provide a better comprehension
of leukemia's trends and are vital for policy-makers for better allocation of the resources. This …

[HTML][HTML] An ultra-fast validated green UPLC-MS/MS approach for assessing revumenib in human liver microsomes: in vitro absorption, distribution, metabolism, and …

MW Attwa, AS Abdelhameed, AA Kadi - Medicina, 2024 - mdpi.com
Background and Objectives: Revumenib (SNDX-5613) is a powerful and specific inhibitor of
the menin–KMT2A binding interaction. It is a small molecule that is currently being …